M ATASSI to Myasthenia Gravis, Autoimmune, Experimental
This is a "connection" page, showing publications M ATASSI has written about Myasthenia Gravis, Autoimmune, Experimental.
Connection Strength
1.721
-
Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice. Autoimmunity. 2017 Sep; 50(6):346-353.
Score: 0.562
-
Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Autoimmunity. 2017 Aug; 50(5):293-305.
Score: 0.552
-
Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. J Neuroimmunol. 2006 Feb; 171(1-2):8-16.
Score: 0.248
-
Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90.
Score: 0.194
-
T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses. Autoimmunity. 2000; 32(1):45-55.
Score: 0.165